Literature DB >> 25369936

Liat1, an arginyltransferase-binding protein whose evolution among primates involved changes in the numbers of its 10-residue repeats.

Christopher S Brower1, Connor E Rosen1, Richard H Jones1, Brandon C Wadas1, Konstantin I Piatkov1, Alexander Varshavsky2.   

Abstract

The arginyltransferase Ate1 is a component of the N-end rule pathway, which recognizes proteins containing N-terminal degradation signals called N-degrons, polyubiquitylates these proteins, and thereby causes their degradation by the proteasome. At least six isoforms of mouse Ate1 are produced through alternative splicing of Ate1 pre-mRNA. We identified a previously uncharacterized mouse protein, termed Liat1 (ligand of Ate1), that interacts with Ate1 but does not appear to be its arginylation substrate. Liat1 has a higher affinity for the isoforms Ate1(1A7A) and Ate1(1B7A). Liat1 stimulated the in vitro N-terminal arginylation of a model substrate by Ate1. All examined vertebrate and some invertebrate genomes encode proteins sequelogous (similar in sequence) to mouse Liat1. Sequelogs of Liat1 share a highly conserved ∼30-residue region that is shown here to be required for the binding of Liat1 to Ate1. We also identified non-Ate1 proteins that interact with Liat1. In contrast to Liat1 genes of nonprimate mammals, Liat1 genes of primates are subtelomeric, a location that tends to confer evolutionary instability on a gene. Remarkably, Liat1 proteins of some primates, from macaques to humans, contain tandem repeats of a 10-residue sequence, whereas Liat1 proteins of other mammals contain a single copy of this motif. Quantities of these repeats are, in general, different in Liat1 of different primates. For example, there are 1, 4, 13, 13, 17, and 17 repeats in the gibbon, gorilla, orangutan, bonobo, neanderthal, and human Liat1, respectively, suggesting that repeat number changes in this previously uncharacterized protein may contribute to evolution of primates.

Entities:  

Keywords:  Ate1; N-end rule; arginylation; primate evolution; tandem repeats

Mesh:

Substances:

Year:  2014        PMID: 25369936      PMCID: PMC4246273          DOI: 10.1073/pnas.1419587111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Arginyltransferase, its specificity, putative substrates, bidirectional promoter, and splicing-derived isoforms.

Authors:  Rong-Gui Hu; Christopher S Brower; Haiqing Wang; Ilia V Davydov; Jun Sheng; Jianmin Zhou; Yong Tae Kwon; Alexander Varshavsky
Journal:  J Biol Chem       Date:  2006-08-30       Impact factor: 5.157

2.  Ubiquitin fusion technique and related methods.

Authors:  Alexander Varshavsky
Journal:  Methods Enzymol       Date:  2005       Impact factor: 1.600

3.  Discovery of cellular regulation by protein degradation.

Authors:  Alexander Varshavsky
Journal:  J Biol Chem       Date:  2008-08-15       Impact factor: 5.157

4.  Rapid expansion and functional divergence of subtelomeric gene families in yeasts.

Authors:  Chris A Brown; Andrew W Murray; Kevin J Verstrepen
Journal:  Curr Biol       Date:  2010-05-13       Impact factor: 10.834

5.  Glutamine-specific N-terminal amidase, a component of the N-end rule pathway.

Authors:  Haiqing Wang; Konstantin I Piatkov; Christopher S Brower; Alexander Varshavsky
Journal:  Mol Cell       Date:  2009-06-26       Impact factor: 17.970

6.  Mouse Dfa is a repressor of TATA-box promoters and interacts with the Abt1 activator of basal transcription.

Authors:  Christopher S Brower; Lucia Veiga; Richard H Jones; Alexander Varshavsky
Journal:  J Biol Chem       Date:  2010-03-31       Impact factor: 5.157

7.  RGS4 and RGS5 are in vivo substrates of the N-end rule pathway.

Authors:  Min Jae Lee; Takafumi Tasaki; Kayoko Moroi; Jee Young An; Sadao Kimura; Ilia V Davydov; Yong Tae Kwon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-10       Impact factor: 11.205

8.  N-terminal acetylation of cellular proteins creates specific degradation signals.

Authors:  Cheol-Sang Hwang; Anna Shemorry; Alexander Varshavsky
Journal:  Science       Date:  2010-01-28       Impact factor: 47.728

9.  Variable number of tandem repeat polymorphisms of DRD4: re-evaluation of selection hypothesis and analysis of association with schizophrenia.

Authors:  Eiji Hattori; Mizuho Nakajima; Kazuo Yamada; Yoshimi Iwayama; Tomoko Toyota; Naruya Saitou; Takeo Yoshikawa
Journal:  Eur J Hum Genet       Date:  2008-12-17       Impact factor: 4.246

10.  Ablation of arginylation in the mouse N-end rule pathway: loss of fat, higher metabolic rate, damaged spermatogenesis, and neurological perturbations.

Authors:  Christopher S Brower; Alexander Varshavsky
Journal:  PLoS One       Date:  2009-11-13       Impact factor: 3.240

View more
  10 in total

1.  Five enzymes of the Arg/N-degron pathway form a targeting complex: The concept of superchanneling.

Authors:  Jang-Hyun Oh; Ju-Yeon Hyun; Shun-Jia Chen; Alexander Varshavsky
Journal:  Proc Natl Acad Sci U S A       Date:  2020-05-04       Impact factor: 11.205

2.  Analyzing N-terminal Arginylation through the Use of Peptide Arrays and Degradation Assays.

Authors:  Brandon Wadas; Konstantin I Piatkov; Christopher S Brower; Alexander Varshavsky
Journal:  J Biol Chem       Date:  2016-08-10       Impact factor: 5.157

3.  The Ligand of Ate1 is intrinsically disordered and participates in nucleolar phase separation regulated by Jumonji Domain Containing 6.

Authors:  Akshaya Arva; Yasar Arfat T Kasu; Jennifer Duncan; Mosleh A Alkhatatbeh; Christopher S Brower
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-21       Impact factor: 11.205

4.  Degradation of the Separase-cleaved Rec8, a Meiotic Cohesin Subunit, by the N-end Rule Pathway.

Authors:  Yu-Jiao Liu; Chao Liu; ZeNan Chang; Brandon Wadas; Christopher S Brower; Zhen-Hua Song; Zhi-Liang Xu; Yong-Liang Shang; Wei-Xiao Liu; Li-Na Wang; Wen Dong; Alexander Varshavsky; Rong-Gui Hu; Wei Li
Journal:  J Biol Chem       Date:  2016-02-08       Impact factor: 5.157

5.  The evolutionarily conserved arginyltransferase 1 mediates a pVHL-independent oxygen-sensing pathway in mammalian cells.

Authors:  Balaji T Moorthy; Chunhua Jiang; Devang M Patel; Yuguang Ban; Corin R O'Shea; Akhilesh Kumar; Tan Yuan; Michael D Birnbaum; Aldrin V Gomes; Xi Chen; Flavia Fontanesi; Theodore J Lampidis; Antoni Barrientos; Fangliang Zhang
Journal:  Dev Cell       Date:  2022-03-04       Impact factor: 12.270

6.  Identification of Targets and Interaction Partners of Arginyl-tRNA Protein Transferase in the Moss Physcomitrella patens.

Authors:  Sebastian N W Hoernstein; Stefanie J Mueller; Kathrin Fiedler; Marc Schuelke; Jens T Vanselow; Christian Schuessele; Daniel Lang; Roland Nitschke; Gabor L Igloi; Andreas Schlosser; Ralf Reski
Journal:  Mol Cell Proteomics       Date:  2016-04-11       Impact factor: 5.911

7.  Beta-amyloid induces apoptosis of neuronal cells by inhibition of the Arg/N-end rule pathway proteolytic activity.

Authors:  Olga I Kechko; Irina Yu Petrushanko; Christopher S Brower; Alexei A Adzhubei; Alexey A Moskalev; Konstantin I Piatkov; Vladimir A Mitkevich; Alexander A Makarov
Journal:  Aging (Albany NY)       Date:  2019-08-24       Impact factor: 5.682

8.  ATE1-Mediated Post-Translational Arginylation Is an Essential Regulator of Eukaryotic Cellular Homeostasis.

Authors:  Verna Van; Aaron T Smith
Journal:  ACS Chem Biol       Date:  2020-11-23       Impact factor: 5.100

9.  Posttranslational arginylation enzyme Ate1 affects DNA mutagenesis by regulating stress response.

Authors:  Akhilesh Kumar; Michael D Birnbaum; Devang M Patel; William M Morgan; Jayanti Singh; Antoni Barrientos; Fangliang Zhang
Journal:  Cell Death Dis       Date:  2016-09-29       Impact factor: 8.469

10.  Distinct transcriptional and metabolic profiles associated with empathy in Buddhist priests: a pilot study.

Authors:  Junji Ohnishi; Satoshi Ayuzawa; Seiji Nakamura; Shigeko Sakamoto; Miyo Hori; Tomoko Sasaoka; Eriko Takimoto-Ohnishi; Masakazu Tanatsugu; Kazuo Murakami
Journal:  Hum Genomics       Date:  2017-09-02       Impact factor: 4.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.